Skip to main content

Tresiba® (insulin degludec injection)

Tresiba® (insulin degludec injection) is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.

The search will retrieve any scientific documents from the medical information database where the search terms match either the title or content of the document. The response(s) are not intended to offer recommendations for administering Novo Nordisk products in a manner inconsistent with approved labeling. To access the Prescribing Information for Novo Nordisk products, please click here.

Search for Letters

Find documents for this product by entering your search terms in the box below.

 

Text: double click to edit.

Have a Question?

Request information directly from the Novo Nordisk
Medical Information department.